- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05914740
Feasibility Study of Ultrasound-guided Functional Remodeling of Lower Extremity Superficial Venous Valve
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
A certain number of patients meeting the requirements (meeting the inclusion criteria, but not meeting the exclusion criteria) were selected for preoperative hemodynamic evaluation of lower extremity vein ultrasound to determine the reflux points and reflux points, identify the blood circulation pattern, and design an individualized surgical program. Intraoperative venous valve was remodeled in situ under ultrasound guidance. Postoperative ultrasound was used to assess venous valve function and complications in the operative area.
Screening period (before surgery 14 days to 0 days) Subject signs informed consent. General information and previous medical history of subjects were collected, preoperative laboratory examination (blood routine, blood biochemistry, coagulation function, preoperative immunity, blood type), electrocardiogram, ultrasound, preoperative hemodynamic evaluation of lower extremity vein were completed, and evaluation scales such as CEAP grading, VCSS, AVVQ, CIVIQ and pain score were completed.
Subjects who meet the inclusion criteria and do not meet all exclusion criteria will be admitted.
Day of surgery (day 0) Preoperative ultrasound was re-evaluated to confirm the valve function, and the tissue was disinfected. Hyaluronic acid was injected around the valve of the great saphenous vein to rebuild the valve about 1-2ml, and the whole process was monitored under ultrasound. During the injection, the valve function was pumped back for protection, and the injection was performed multiple times at different points. Supplementary injection: Following the subject's voluntary principle, the researcher can give supplementary injection after evaluating the general condition of the subject.
The follow-up period for each subject was 12 months ±20 days after enrollment. Follow-up period (±3 days at 1 week, ±5 days at 1 month, ±10 days at 3 months, ±15 days at 6 months, ±20 days at 1 year) General data of subjects were collected, laboratory examination (blood routine and blood biochemistry) and postoperative ultrasound hemodynamic evaluation of lower limb veins were improved, and evaluation scales such as VCSS, AVVQ, CIVIQ and pain score were completed.
This study does not involve vulnerable groups.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Yuefeng Zhu, Master's
- Phone Number: 13868101010
- Email: zhuyuefeng@126.com
Study Locations
-
-
Zhejiang Procince
-
Yiwu, Zhejiang Procince, China, 322000
- Recruiting
- The Fourth Affiliated Hospital Zhejiang University School of Medicine
-
Contact:
- Yuefeng Zhu
- Phone Number: 13868101010
- Email: srrshzyf@zju.edu.cn
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Age 18-80, gender unlimited
- CEAP grading was C2-C5 patients
- The patient was clinically diagnosed as a primary varicose great saphenous vein of lower extremity, and the ultrasound findings were great saphenous vein valve insufficiency (complete structure, normal shape, enlarged valve ring, Duration of reflux >0.5s), only unilateral varicose great saphenous vein was treated this time
Exclusion Criteria:
- Patients with target vessel diameter < 3mm
- The final valve of the great saphenous vein was not clear or lost its normal shape on ultrasound
- Patients with deep vein valvular insufficiency
- The presence of thrombus or thrombophlebitis in the main trunk of great cryptic skin
- Target diseased blood vessel had previously received surgical treatment
- Patients with deep vein thrombosis or history of pulmonary distension embolism
- Patients with active implants such as pacemakers or ICDs
- Patients with severe abnormal liver and kidney function (more than three times the normal value)
- Patients with non-primary varicose veins caused by post-deep vein thrombosis syndrome, Cockett syndrome (iliac vein compression syndrome), KT syndrome (venous malformation hypertrophy syndrome >, arteriovenous sputum, etc
- Any serious or uncontrolled systemic disease (including poorly medicated hypertension, diabetes, and diseases with active bleeding signs or severe coagulopathy)
- Patients with diseases that may make treatment and evaluation difficult (e.g., malignant arsine tumor, acute infectious diseases, sepsis, systemic intolerability of surgery, life expectancy less than 12 months, etc.)
- Pregnant and lactating women, or those who planned to have children during the study period
- Patients who have participated in clinical trials of other drugs or medical devices within the last 3 months
- Anesthetist and other patients were deemed unsuitable for the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Venous valve remodeling
Venous valve function was remodeled under ultrasound guidance
|
Preoperative ultrasound was used to re-evaluate and confirm the valve function, disinfect the tissue, inject hyaluronic acid around the great saphenous vein valve to reshape the valve about 1-2ml, monitor the whole process under ultrasound, pump back for protection during injection, and inject multiple times at different points.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Venous valve regurgitation or not
Time Frame: immediately after intervention
|
Under the calf compression test, the venous valves were observed for blood flow regurgitation signal
|
immediately after intervention
|
Venous valve regurgitation or not
Time Frame: 1 week after intervention
|
Under the calf compression test, the venous valves were observed for blood flow regurgitation signal
|
1 week after intervention
|
Venous valve regurgitation or not
Time Frame: 1 month after intervention
|
Under the calf compression test, the venous valves were observed for blood flow regurgitation signal
|
1 month after intervention
|
Venous valve regurgitation or not
Time Frame: 3 months after intervention
|
Under the calf compression test, the venous valves were observed for blood flow regurgitation signal
|
3 months after intervention
|
Venous valve regurgitation or not
Time Frame: 6 months after intervention
|
Under the calf compression test, the venous valves were observed for blood flow regurgitation signal
|
6 months after intervention
|
Venous valve regurgitation or not
Time Frame: 1 year after intervention
|
Under the calf compression test, the venous valves were observed for blood flow regurgitation signal
|
1 year after intervention
|
Changes in the duration of venous valve regurgitation
Time Frame: immediately after intervention
|
The duration of venous valve regurgitation was measured under calf compression test
|
immediately after intervention
|
Changes in the duration of venous valve regurgitation
Time Frame: 1 week after intervention
|
The duration of venous valve regurgitation was measured under calf compression test
|
1 week after intervention
|
Changes in the duration of venous valve regurgitation
Time Frame: 1 month after intervention
|
The duration of venous valve regurgitation was measured under calf compression test
|
1 month after intervention
|
Changes in the duration of venous valve regurgitation
Time Frame: 3 months after intervention
|
The duration of venous valve regurgitation was measured under calf compression test
|
3 months after intervention
|
Changes in the duration of venous valve regurgitation
Time Frame: 6 months after intervention
|
The duration of venous valve regurgitation was measured under calf compression test
|
6 months after intervention
|
Changes in the duration of venous valve regurgitation
Time Frame: 1 year after intervention
|
The duration of venous valve regurgitation was measured under calf compression test
|
1 year after intervention
|
Collaborators and Investigators
Investigators
- Study Director: Yuefeng Zhu, Master's, The Fourth Affiliated Hospital Zhejiang University School of Medicine
Publications and helpful links
General Publications
- De Maeseneer MG, Kakkos SK, Aherne T, Baekgaard N, Black S, Blomgren L, Giannoukas A, Gohel M, de Graaf R, Hamel-Desnos C, Jawien A, Jaworucka-Kaczorowska A, Lattimer CR, Mosti G, Noppeney T, van Rijn MJ, Stansby G, Esvs Guidelines Committee, Kolh P, Bastos Goncalves F, Chakfe N, Coscas R, de Borst GJ, Dias NV, Hinchliffe RJ, Koncar IB, Lindholt JS, Trimarchi S, Tulamo R, Twine CP, Vermassen F, Wanhainen A, Document Reviewers, Bjorck M, Labropoulos N, Lurie F, Mansilha A, Nyamekye IK, Ramirez Ortega M, Ulloa JH, Urbanek T, van Rij AM, Vuylsteke ME. Editor's Choice - European Society for Vascular Surgery (ESVS) 2022 Clinical Practice Guidelines on the Management of Chronic Venous Disease of the Lower Limbs. Eur J Vasc Endovasc Surg. 2022 Feb;63(2):184-267. doi: 10.1016/j.ejvs.2021.12.024. Epub 2022 Jan 11. No abstract available. Erratum In: Eur J Vasc Endovasc Surg. 2022 Aug-Sep;64(2-3):284-285.
- Muhlberger D, Brenner E, Frings N, Geier B, Mumme A, Reich-Schupke S, Steffen HP, Stenger D, Stucker M, Hummel T. Functional repair of the great saphenous vein by external valvuloplasty reduces the vein's diameter: 6-month results of a multicentre study. J Int Med Res. 2021 May;49(5):3000605211014364. doi: 10.1177/03000605211014364.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- K2022110
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Varicose Veins of Lower Limb
-
I-VASC S.r.lRecruiting
-
Acotec Scientific Co., LtdZhejiang UniversityCompletedVaricose Veins of Lower LimbChina
-
Beijing Tsinghua Chang Gung HospitalActive, not recruiting
-
Oulu University HospitalCompletedVaricose Veins | Varicose Veins of Lower LimbFinland
-
Societe Francaise de PhlebologieCompletedVaricose Veins of Lower Limb
-
The University of Hong Kong-Shenzhen HospitalUnknown
-
Peking University People's HospitalPeking University First Hospital; First Affiliated Hospital Xi'an Jiaotong... and other collaboratorsActive, not recruiting
-
Worcestershire Acute Hospitals NHS TrustCompletedVaricose Veins of Lower LimbUnited Kingdom
-
Pirogov Russian National Research Medical UniversityCompletedVaricose Veins | Varicose Veins of Lower LimbRussian Federation
-
Helsinki University Central HospitalCompletedVaricose Veins of Lower Limb